<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03479424</url>
  </required_header>
  <id_info>
    <org_study_id>18-24445</org_study_id>
    <nct_id>NCT03479424</nct_id>
  </id_info>
  <brief_title>Home Outpatient Monitoring and Engagement to Predict HF Exacerbation</brief_title>
  <acronym>Home Predict</acronym>
  <official_title>Home Outpatient Monitoring and Engagement to Predict HF Exacerbation (HOME PREDICT-HF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MYIA Labs, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The HOME PREDICT HF study looks at new ways to predict hospitalizations for heart failure. We&#xD;
      will use a set of devices at home and surveys to collect information about patient's health.&#xD;
      This study uses the Eureka app, a new study app developed by the University of California,&#xD;
      San Francisco. The study is designed to happen remotely, using this application on a&#xD;
      patient's smartphone, so that is as convenient as possible to participate.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      HOME PREDICT HF is single center, prospective, unblinded, randomly assigned training and&#xD;
      validation observational cohorts to develop machine learning algorithms from an in-home suite&#xD;
      of sensors in order to predict 3-month heart failure hospitalization and/or emergency&#xD;
      department visits. Study population includes adults presenting with a diagnosis of reduced&#xD;
      ejection fraction (LVEF &lt;= 40%), NYHA class II-IV) who have had a hospitalization for HF in&#xD;
      the previous 6 months. The study objectives include (1) To collect observational data from&#xD;
      multiple sensors, patient-reported outcomes, and medical record data to develop (train)&#xD;
      machine-learning algorithms (2) To validate trained algorithms in a separate validation&#xD;
      cohort (3) To collect data to inform the design of a future intervention study. The primary&#xD;
      outcome is Ninety-day heart failure hospitalization/emergency department visit for heart&#xD;
      failure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Slow recruitment&#xD;
  </why_stopped>
  <start_date type="Actual">October 8, 2018</start_date>
  <completion_date type="Actual">March 1, 2019</completion_date>
  <primary_completion_date type="Actual">March 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Heart Failure Hospitalization/ ED Visit</measure>
    <time_frame>90 day</time_frame>
    <description>Ninety-day heart failure hospitalization/emergency department visit for heart failure.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Heart Failure With Reduced Ejection Fraction</condition>
  <arm_group>
    <arm_group_label>Training Set</arm_group_label>
    <description>n = 333</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Validation Set</arm_group_label>
    <description>n = 167</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational</intervention_name>
    <description>The MYIA in-home suite of devices.</description>
    <arm_group_label>Training Set</arm_group_label>
    <arm_group_label>Validation Set</arm_group_label>
    <other_name>The MYIA in-home suite of devices.</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults presenting with a diagnosis of reduced ejection fraction (LVEF &lt;= 40%), NYHA class&#xD;
        II-IV) who have had a hospitalization for HF in the previous 6 months.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Outpatient and cared for by a PINNACLE Registry practice&#xD;
&#xD;
          2. Age ≥ 18 years old&#xD;
&#xD;
          3. Has a diagnosis of HF in the PINNACLE Registry/Medical Record&#xD;
&#xD;
          4. Seen by PINNACLE practice within the last 12 months&#xD;
&#xD;
          5. Has an LVEF ≤40% on their last data entry (within 1 year) in the PINNACLE Registry&#xD;
&#xD;
          6. NYHA Class II-IV by self-report&#xD;
&#xD;
          7. Has had a hospitalization for HF in the previous 6 months by self-report&#xD;
&#xD;
          8. Owns an Android or iOS smartphone, within Verizon cellular coverage zone in order to&#xD;
             allow for data submission.&#xD;
&#xD;
          9. Sleep in the same bed at least 5 days per week&#xD;
&#xD;
         10. Willingness to complete the required surveys, measurements and study activities.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Home oxygen use&#xD;
&#xD;
          2. Current or planned ventricular assist device&#xD;
&#xD;
          3. Previously or currently on a heart transplant list&#xD;
&#xD;
          4. Chronic dialysis&#xD;
&#xD;
          5. A diagnosis of any cancer and undergoing active treatment&#xD;
&#xD;
          6. In hospice or palliative care&#xD;
&#xD;
          7. Planned surgery/procedure in the next 3 months&#xD;
&#xD;
          8. Planned extended time away from home (&gt;2 weeks) in the next 3 months&#xD;
&#xD;
          9. Living in a skilled nursing facility or other chronic care facility&#xD;
&#xD;
         10. Pregnancy or planned pregnancy in the next 3 months&#xD;
&#xD;
         11. Inability or unwillingness to consent and/or follow requirements of the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeff Olgin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>March 20, 2018</study_first_submitted>
  <study_first_submitted_qc>March 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2018</study_first_posted>
  <last_update_submitted>December 18, 2019</last_update_submitted>
  <last_update_submitted_qc>December 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hospitalization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

